FDA Data Shows Medtronic Stent Has Higher Death Rate

Medtronic’s AneuRx stent-graft system has had a higher death rate than conventional surgical options, according to the FDA, which posted its findings on its website. The stent is designed to treat abdominal aortic aneurysms, a potentially life-threatening condition in which the aortic artery bulges and can burst resulting in death. This latest FDA warning comes on the heels of Medtronic’s Sprint Fidelis cardiac defibrillators whose leads have been found to fracture causing electrical shorts. The culprit in the Fidelis defibrillators is the leads which are thin wires that send electrical impulses to the heart regulating the cardiac rhythm.